Werfen to Acquire Immucor, Inc., Expanding its Presence in Specialized Diagnostics
By asianet
— Werfen enters into an agreement to acquire Immucor, Inc., a privately held, US-based corporation, with a solid global presence in transfusion and transplant in vitro diagnostics — The transaction is expected to close during the first half of 2023 Werfen announced today that it has agreed to acquire Immucor, Inc., from TPG. Immucor is … Continued